Keros Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $4.8k | 234 | 20.36 |
| 2024-12-31 | $1.0M | 64k | 15.83 |
| 2024-09-30 | $2.9M | 51k | 58.07 |
| 2024-06-30 | $2.2M | 48k | 45.70 |
| 2024-03-31 | $1.1M | 17k | 66.20 |
| 2023-12-31 | $681k | 17k | 39.76 |
| 2023-09-30 | $353k | 11k | 31.88 |
| 2023-06-30 | $732k | 17k | 42.70 |
| 2023-03-31 | $732k | 17k | 42.70 |
| 2022-12-31 | $823k | 17k | 48.02 |
| 2022-09-30 | $645k | 17k | 37.62 |
| 2022-06-30 | $306k | 11k | 27.63 |
| 2022-03-31 | $436k | 8.0k | 54.38 |
| 2021-12-31 | $469k | 8.0k | 58.51 |
| 2021-03-31 | $431k | 7.0k | 61.55 |
| 2020-12-31 | $430k | 6.1k | 70.54 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas